TY - JOUR
T1 - A patient-specific in silico model of inflammation and healing tested in acute vocal fold injury
AU - Li, Nicole Y.K.
AU - Verdolini, Katherine
AU - Clermont, Gilles
AU - Mi, Qi
AU - Rubinstein, Elaine N.
AU - Hebda, Patricia A.
AU - Vodovotz, Yoram
PY - 2008/7/30
Y1 - 2008/7/30
N2 - The development of personalized medicine is a primary objective of the medical community and increasingly also of funding and registration agencies. Modeling is generally perceived as a key enabling tool to target this goal. Agent-Based Models (ABMs) have previously been used to simulate inflammation at various scales up to the whole-organism level. We extended this approach to the case of a novel, patient-specific ABM that we generated for vocal fold inflammation, with the ultimate goal of identifying individually optimized treatments. ABM simulations reproduced trajectories of inflammatory mediators in laryngeal secretions of individuals subjected to experimental phonotrauma up to 4 hrs post-injury, and predicted the levels of inflammatory mediators 24 hrs post-injury. Subject-specific simulations also predicted different outcomes from behavioral treatment regimens to which subjects had not been exposed. We propose that this translational application of computational modeling could be used to design patient-specific therapies for the larynx, and will serve as a paradigm for future extension to other clinical domains.
AB - The development of personalized medicine is a primary objective of the medical community and increasingly also of funding and registration agencies. Modeling is generally perceived as a key enabling tool to target this goal. Agent-Based Models (ABMs) have previously been used to simulate inflammation at various scales up to the whole-organism level. We extended this approach to the case of a novel, patient-specific ABM that we generated for vocal fold inflammation, with the ultimate goal of identifying individually optimized treatments. ABM simulations reproduced trajectories of inflammatory mediators in laryngeal secretions of individuals subjected to experimental phonotrauma up to 4 hrs post-injury, and predicted the levels of inflammatory mediators 24 hrs post-injury. Subject-specific simulations also predicted different outcomes from behavioral treatment regimens to which subjects had not been exposed. We propose that this translational application of computational modeling could be used to design patient-specific therapies for the larynx, and will serve as a paradigm for future extension to other clinical domains.
UR - http://www.scopus.com/inward/record.url?scp=50949091234&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0002789
DO - 10.1371/journal.pone.0002789
M3 - Article
C2 - 18665229
AN - SCOPUS:50949091234
SN - 1932-6203
VL - 3
JO - PLoS ONE
JF - PLoS ONE
IS - 7
M1 - e2789
ER -